Transplantation Immunology and Immunogenetics

End stage failure of organs the system is lacking ability to tell apart the existence of helpful and harmful foreign pathogens. System has developed effective mechanisms to fight foreign agents therefore these mechanisms area unit concerned in transplant rejection. Graft-versus-host diseases area unit common issues in allogeneic tissue transplantation. Rejection is associate adaptive reaction that comes through cellular immunity and conjointly by body substance immunity although the action is joined by elements of innate reaction i.e. soluble immune differing kinds of transplanted tissues tend to favour various balances of rejection mechanisms. Today, most recipients of transplants area unit maintained on immunological disorder medication. The side-effects of such antirejection medication, which might themselves be life threatening, embrace increased risk of infection, cancer, diabetes, and different conditions. In time, however, several patients develop a tolerance to the deep-seated organs, and a few will eventually be weaned off the medication.

  • Allogeneic tissue transplantation
  • Cellular immunity
  • Immunological disorder medication
  • Differing kinds of transplanted tissues

Related Conference of Transplantation Immunology and Immunogenetics

April 18-19, 2024

7th World Congress on Surgeons

Dubai, UAE
September 16-17, 2024

2nd Annual Conference on Surgery

Paris, France
October 22-23, 2024

2nd Global Summit on Geriatrics & Aging

Paris, France

Transplantation Immunology and Immunogenetics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in